CN Patent

CN112125868B — 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途

Assigned to Zhongshan Wanyuan New Drugs Research And Development Co ltd · Expires 2021-08-03 · 5y expired

What this patent protects

本发明涉及医药技术领域，具体涉及一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途。所述氢溴酸伏硫西汀晶型的X‑射线衍射图谱至少在2θ±0.2°位置有特征峰，所述2θ为7.0、13.9、14.7、20.8和29.8。本发明具有溶解度和口服生物利用度显著提高、安全、制备工艺简单、适合工业化生产的优点。

USPTO Abstract

本发明涉及医药技术领域，具体涉及一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途。所述氢溴酸伏硫西汀晶型的X‑射线衍射图谱至少在2θ±0.2°位置有特征峰，所述2θ为7.0、13.9、14.7、20.8和29.8。本发明具有溶解度和口服生物利用度显著提高、安全、制备工艺简单、适合工业化生产的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN112125868B
Jurisdiction
CN
Classification
—
Expires
2021-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Zhongshan Wanyuan New Drugs Research And Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.